Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40ZGL | ISIN: US08659B1026 | Ticker-Symbol:
NASDAQ
27.06.25 | 21:59
15,070 US-Dollar
+0,53 % +0,080
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BETA BIONICS INC Chart 1 Jahr
5-Tage-Chart
BETA BIONICS INC 5-Tage-Chart

Aktuelle News zur BETA BIONICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoBBNX Stock May Gain From Abbott Deal to Advance iLet Integration2
BETA BIONICS Aktie jetzt für 0€ handeln
MoBeta Bionics, Inc. - 8-K, Current Report1
MoAnalysts expect Beta Bionics patch pump launch by 20274
19.06.Beta Bionics to pair iLet automated insulin delivery system with Abbott's dual glucose-ketone sensor2
19.06.Beta Bionics, Inc.: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor157IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet...
► Artikel lesen
16.06.Beta Bionics stock initiated with Buy rating at Truist Securities5
01.06.Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating2
30.05.Goldman Sachs stuft Beta Bionics-Aktie mit Neutral-Rating und Kursziel von 16 US-Dollar ein5
30.05.Goldman Sachs sets Beta Bionics stock at Neutral with $16 target2
07.05.Beta Bionics Q1 2025 slides: raised guidance despite earnings miss3
06.05.Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M2
06.05.Beta Bionics, Inc. - 10-Q, Quarterly Report2
06.05.Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025493IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results...
► Artikel lesen
16.04.Beta Bionics, Inc.: Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 20251
09.04.Beta Bionics, Inc.: Beta Bionics to Host Investor Event on June 22, 20252
04.04.Stifel maintains Buy rating on Beta Bionics stock, target at $256
28.03.Beta Bionics, Inc. - 10-K/A, Annual Report1
27.03.Beta Bionics appoints new board member from Delcath Systems1
27.03.Beta Bionics ernennt neues Vorstandsmitglied von Delcath Systems4
27.03.Beta Bionics, Inc.: Beta Bionics Announces Board Appointment of Gerard Michel1
Weiter >>
62 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1